Characteristics, Outcomes, and Factors Affecting Mortality in Hospitalized Patients with CAP Due to Different Variants of SARS-CoV-2 and Non-COVID-19 CAP.

Nonthanat Tongsengkee, Smonrapat Surasombatpattana, Wiwatana Tanomkiat, Pisud Siripaitoon, Narongdet Kositpantawong, Siripen Kanchanasuwan, Asma Navasakulpong, Nawamin Pinpathomrat, Arunee Dechaphunkul, Atthaphong Phongphithakchai, Thanaporn Hortiwakul, Boonsri Charoenmak, Sarunyou Chusri
Author Information
  1. Nonthanat Tongsengkee: Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
  2. Smonrapat Surasombatpattana: Department of Pathology, Division of Virology and Serology, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
  3. Wiwatana Tanomkiat: Department of Radiology, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
  4. Pisud Siripaitoon: Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
  5. Narongdet Kositpantawong: Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand. ORCID
  6. Siripen Kanchanasuwan: Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand. ORCID
  7. Asma Navasakulpong: Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
  8. Nawamin Pinpathomrat: Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand. ORCID
  9. Arunee Dechaphunkul: Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
  10. Atthaphong Phongphithakchai: Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
  11. Thanaporn Hortiwakul: Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
  12. Boonsri Charoenmak: Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
  13. Sarunyou Chusri: Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand. ORCID

Abstract

The study was conducted from October 2020 to March 2022 in a province in southern Thailand. The inpatients with community-acquired pneumonia (CAP) and more than 18 years old were enrolled. Of the 1511 inpatients with CAP, COVID-19 was the leading cause, accounting for 27%. Among the patients with COVID-19 CAP, mortalities, mechanical ventilators, ICU admissions, ICU stay, and hospital costs were significantly higher than of those with Non-COVID-19 CAP. Household and workplace contact with COVID-19, co-morbidities, lymphocytopenia and peripheral infiltration in chest imaging were associated with CAP due to COVID-19. The delta variant yielded the most unfavorable clinical and non-clinical outcomes. While COVID-19 CAP due to B.1.113, Alpha and Omicron variants had relatively similar outcomes. Among those with CAP, COVID-19 infection as well as obesity, a higher Charlson comorbidity index (CCI) and APACHE II score were associated with in-hospital mortality. Among those with COVID-19 CAP, obesity, infection due to the Delta variant, a higher CCI and higher APACHE II score were associated with in-hospital mortality. COVID-19 had a great impact on the epidemiology and outcomes of CAP.

Keywords

References

  1. J Am Coll Radiol. 2020 Jun;17(6):701-709 [PMID: 32283052]
  2. Postgrad Med. 2015 Aug;127(6):607-15 [PMID: 26224210]
  3. N Engl J Med. 2020 Apr 30;382(18):1708-1720 [PMID: 32109013]
  4. Emerg Microbes Infect. 2022 Dec;11(1):585-592 [PMID: 35114893]
  5. Virol J. 2020 Oct 21;17(1):159 [PMID: 33087181]
  6. Indian J Med Res. 2020 Apr;151(4):287-302 [PMID: 32461392]
  7. Lancet Microbe. 2022 May;3(5):e348-e356 [PMID: 35345417]
  8. Lancet Oncol. 2020 Oct;21(10):1309-1316 [PMID: 32853557]
  9. Nat Rev Immunol. 2020 Nov;20(11):709-713 [PMID: 33024281]
  10. Nat Cancer. 2022 May;3(5):547-551 [PMID: 35379984]
  11. Eur Respir J. 2020 May 14;55(5): [PMID: 32217650]
  12. Am J Respir Crit Care Med. 2002 Sep 1;166(5):717-23 [PMID: 12204871]
  13. Cochrane Database Syst Rev. 2022 Jun 13;6:CD015209 [PMID: 35695334]
  14. Viruses. 2022 Mar 19;14(3): [PMID: 35337047]
  15. N Engl J Med. 2015 Jul 30;373(5):415-27 [PMID: 26172429]
  16. Thorax. 2011 Apr;66(4):340-6 [PMID: 21257985]
  17. Blood. 2020 Dec 17;136(25):2905-2917 [PMID: 33331927]
  18. Respir Res. 2022 Jan 29;23(1):18 [PMID: 35093079]
  19. Lancet Reg Health Am. 2022 Aug;12:100297 [PMID: 35756977]
  20. Lancet. 2021 Jan 9;397(10269):99-111 [PMID: 33306989]
  21. Gene Rep. 2021 Jun;23:101077 [PMID: 33723522]
  22. JAMA. 2020 Mar 17;323(11):1061-1069 [PMID: 32031570]
  23. J Infect. 2020 Aug;81(2):e16-e25 [PMID: 32335169]
  24. Clin Chest Med. 2005 Mar;26(1):47-55 [PMID: 15802165]
  25. J Med Virol. 2021 Jan;93(1):241-249 [PMID: 32579236]
  26. Cochrane Database Syst Rev. 2021 Mar 18;3:CD013881 [PMID: 33734435]
  27. Am J Respir Crit Care Med. 2005 Feb 15;171(4):388-416 [PMID: 15699079]
  28. Toxins (Basel). 2020 Jul 05;12(7): [PMID: 32635646]
  29. Cell. 2020 Nov 12;183(4):996-1012.e19 [PMID: 33010815]
  30. J Infect Dis. 2023 Feb 1;227(3):344-352 [PMID: 36214810]
  31. Clin Infect Dis. 2017 Nov 13;65(11):1806-1812 [PMID: 29020164]
  32. Lancet. 2020 Jun 20;395(10241):1907-1918 [PMID: 32473681]
  33. J Intensive Med. 2021 Aug 07;1(2):71-80 [PMID: 36785564]
  34. Aging Male. 2020 Dec;23(5):1416-1424 [PMID: 32508193]
  35. Clin Infect Dis. 2022 Aug 24;75(1):e1128-e1136 [PMID: 34423834]
  36. Front Cell Infect Microbiol. 2020 Dec 18;10:605334 [PMID: 33392109]
  37. Clin Microbiol Infect. 2011 Nov;17 Suppl 6:E1-59 [PMID: 21951385]
  38. N Engl J Med. 2021 Sep 2;385(10):875-884 [PMID: 34233097]
  39. World J Urol. 2021 Aug;39(8):2987-2993 [PMID: 33481113]
  40. Lancet Reg Health Southeast Asia. 2023 Jan;8:100106 [PMID: 36349259]
  41. PLoS Pathog. 2021 Sep 2;17(9):e1009850 [PMID: 34473802]
  42. Open Forum Infect Dis. 2020 Nov 29;8(1):ofaa560 [PMID: 33447631]
  43. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67 [PMID: 31573350]
  44. Int Urol Nephrol. 2020 Jun;52(6):1193-1194 [PMID: 32222883]
  45. Sci Rep. 2021 Apr 20;11(1):8562 [PMID: 33879826]
  46. Eur Respir J. 2020 Apr 16;55(4): [PMID: 32269085]
  47. J Virol. 2020 Mar 17;94(7): [PMID: 31996437]
  48. Elife. 2021 Aug 20;10: [PMID: 34414884]
  49. Respir Investig. 2022 Nov;60(6):772-778 [PMID: 36050273]
  50. CMAJ. 2022 Feb 22;194(7):E242-E251 [PMID: 35045989]
  51. N Engl J Med. 2013 Jul 11;369(2):155-63 [PMID: 23841730]
  52. N Engl J Med. 2021 Feb 4;384(5):403-416 [PMID: 33378609]
  53. Ann Fam Med. 2016 Nov;14(6):552-566 [PMID: 28376442]
  54. Cell Rep. 2022 May 17;39(7):110829 [PMID: 35550680]
  55. Infect Drug Resist. 2021 Sep 17;14:3809-3816 [PMID: 34557004]
  56. Cochrane Database Syst Rev. 2021 Aug 16;8:CD014963 [PMID: 34396514]
  57. Mol Ther Nucleic Acids. 2021 Dec 3;26:237-241 [PMID: 34484868]
  58. Lancet Oncol. 2020 Mar;21(3):335-337 [PMID: 32066541]
  59. Sci Rep. 2022 May 30;12(1):9004 [PMID: 35637232]
  60. Am J Infect Control. 2008 Jun;36(5):309-32 [PMID: 18538699]
  61. Chest. 2008 Mar;133(3):610-7 [PMID: 17989157]
  62. Semin Respir Crit Care Med. 2016 Dec;37(6):839-854 [PMID: 27960208]
  63. J Med Assoc Thai. 2014 Mar;97(3):283-92 [PMID: 25123007]
  64. Lancet. 2020 Feb 15;395(10223):497-506 [PMID: 31986264]
  65. Lancet. 2022 Apr 2;399(10332):1303-1312 [PMID: 35305296]
  66. J Med Virol. 2020 Jun;92(6):577-583 [PMID: 32162702]
  67. J Med Assoc Thai. 2006 Sep;89(9):1412-9 [PMID: 17100378]
  68. BMC Infect Dis. 2022 Aug 22;22(1):702 [PMID: 35996076]
  69. Lancet Respir Med. 2020 Apr;8(4):e21 [PMID: 32171062]
  70. N Engl J Med. 2020 Nov 5;383(19):1813-1826 [PMID: 32445440]
  71. J Med Econ. 2022 Jan-Dec;25(1):912-918 [PMID: 35726515]
  72. Int J Infect Dis. 2020 Feb;91:264-266 [PMID: 31953166]
  73. Eur Heart J Open. 2021 Jun 15;1(1):oeab001 [PMID: 35919090]
  74. BMJ. 2022 Aug 2;378:e070695 [PMID: 35918098]
  75. Infect Dis (Lond). 2020 Jul;52(7):479-488 [PMID: 32319831]
  76. N Engl J Med. 2020 Dec 31;383(27):2603-2615 [PMID: 33301246]
  77. Immun Ageing. 2019 May 21;16:11 [PMID: 31139232]
  78. Folia Microbiol (Praha). 2022 Aug 12;: [PMID: 35962276]
  79. Lancet Infect Dis. 2022 Jan;22(1):35-42 [PMID: 34461056]

Grants

  1. P-20-50620/National Science and Technology Development Agency

Word Cloud

Created with Highcharts 10.0.0CAPCOVID-19higheroutcomesAmongassociateddueThailandinpatientscommunity-acquiredpneumoniaICUvariantinfectionobesityCCIAPACHEIIscorein-hospitalmortalityepidemiologySARS-CoV-2studyconductedOctober2020March2022provincesouthern18yearsoldenrolled1511leadingcauseaccounting27%patientsmortalitiesmechanicalventilatorsadmissionsstayhospitalcostssignificantlynon-COVID-19Householdworkplacecontactco-morbiditieslymphocytopeniaperipheralinfiltrationchestimagingdeltayieldedunfavorableclinicalnon-clinicalB1113AlphaOmicronvariantsrelativelysimilarwellCharlsoncomorbidityindexDeltagreatimpactCharacteristicsOutcomesFactorsAffectingMortalityHospitalizedPatientsDueDifferentVariantsNon-COVID-19

Similar Articles

Cited By (2)